Published in Dtsch Med Wochenschr on December 13, 1996
Haemorrhagic complications of pancreatitis: presentation, diagnosis and management. Ann R Coll Surg Engl (1998) 1.18
Endovascular management of hemosuccus pancreaticus, a rare case report of gastrointestinal bleeding. BMC Gastroenterol (2016) 0.75
Sclerotherapy of bleeding oesophageal varices by means of endoscopy. Endoscopy (1978) 2.10
Prophylactic endoscopic sclerosing treatment of the esophageal wall in varices -- a prospective controlled randomized trial. Endoscopy (1982) 2.01
Escalation to weekly dosing recaptures response in adalimumab-treated patients with moderately to severely active ulcerative colitis. Aliment Pharmacol Ther (2014) 1.56
Experience with percutaneous dilational tracheostomy. Ann Otol Rhinol Laryngol (2000) 1.56
Interpersonal influences in adolescent drug use--the role of older siblings, parents, and peers. Int J Addict (1986) 1.53
Prevention of transfusion-associated cytomegalovirus infection in neonatal patients by the removal of white cells from blood. Transfusion (1992) 1.47
Structures of recombinant native and E202Q mutant human acetylcholinesterase complexed with the snake-venom toxin fasciculin-II. Acta Crystallogr D Biol Crystallogr (2000) 1.47
Management of myasthenia gravis. J Assoc Physicians India (1991) 1.39
[Nosological, pathological-anatomical, diagnostic and therapeutic aspects of intralobar pulmonary sequestration]. Thoraxchir Vask Chir (1971) 1.35
Production and secretion of high levels of recombinant human acetylcholinesterase in cultured cell lines: microheterogeneity of the catalytic subunit. Gene (1992) 1.28
Limited hepatic resection for selected cirrhotic patients with hepatocellular or cholangiocellular carcinoma: a prospective study. Br J Surg (1991) 1.27
One-year maintenance outcomes among patients with moderately-to-severely active ulcerative colitis who responded to induction therapy with adalimumab: subgroup analyses from ULTRA 2. Aliment Pharmacol Ther (2012) 1.24
Vimentin is a novel AKT1 target mediating motility and invasion. Oncogene (2010) 1.23
Effect of an antiretroviral regimen containing ritonavir boosted lopinavir on intestinal and hepatic CYP3A, CYP2D6 and P-glycoprotein in HIV-infected patients. Clin Pharmacol Ther (2008) 1.23
Endoscopic sclerosis and esophageal balloon tamponade in acute hemorrhage from esophagogastric varices: a prospective controlled randomized trial. Hepatology (1985) 1.23
The clinical role of genetic polymorphisms in drug-metabolizing enzymes. Pharmacogenomics J (2007) 1.21
Humoral and cellular immune responses of seronegative children vaccinated with a cold-adapted influenza A/HK/123/77 (H1N1) recombinant virus. Infect Immun (1980) 1.19
Acetylcholinesterase peripheral anionic site degeneracy conferred by amino acid arrays sharing a common core. J Biol Chem (1994) 1.14
The effect of elimination of intersubunit disulfide bonds on the activity, assembly, and secretion of recombinant human acetylcholinesterase. Expression of acetylcholinesterase Cys-580----Ala mutant. J Biol Chem (1991) 1.10
Allosteric modulation of acetylcholinesterase activity by peripheral ligands involves a conformational transition of the anionic subsite. Biochemistry (1995) 1.00
Characterization and mixed infections of three strains of vaccinia virus: wild type, IBT-resistant and IBT-dependent mutants. J Gen Virol (1973) 0.99
Varieties of long-term outcome among patients in psychoanalysis and long-term psychotherapy. A review of findings in the Stockholm Outcome of Psychoanalysis and Psychotherapy Project (STOPP). Int J Psychoanal (2000) 0.98
Analysis of factors affecting outcome after hepatectomy of patients with liver cirrhosis and small hepatocellular carcinoma. Eur J Surg (1998) 0.97
Expression of the hyaluronan receptor RHAMM in endometrial carcinomas suggests a role in tumour progression and metastasis. J Cancer Res Clin Oncol (2003) 0.97
[Conservative therapy of acute massive hemorrhage from esophageal varices]. Dtsch Med Wochenschr (1971) 0.95
Extraneuronal monoamine transporter and organic cation transporters 1 and 2: a review of transport efficiency. Handb Exp Pharmacol (2006) 0.95
Management of acute bleeding from gastroesophageal varices. J Cardiovasc Surg (Torino) (1971) 0.94
Cirrhosis, gram-negative sepsis and chloramphenicol toxicity. Am J Gastroenterol (1966) 0.91
Dermal absorption of permethrin following topical administration. Eur J Clin Pharmacol (2005) 0.90
Prevention and diagnosis of delayed haemolytic transfusion reactions. Vox Sang (2006) 0.90
[Guidelines and results of consequent fibrinolytic therapy in phlegmasia cerulea dolens]. Dtsch Med Wochenschr (1970) 0.89
Trichomonas vaginalis infection. Incidence with use of various contraceptive methods. J Med Soc N J (1970) 0.88
Massive and recurrent gastrointestinal hemorrhage due to jejunal varices in an afferent loop--diagnosis and management. Hepatogastroenterology (1994) 0.88
Ten years experience with paravariceal injection sclerotherapy of esophageal varices in children. J Pediatr Surg (1985) 0.88
Management of osteomas of the paranasal sinuses. Am J Rhinol (1999) 0.86
Cell-mediated immune response of human lymphocytes to influenza A/USSR (H1N1) virus infection. Infect Immun (1980) 0.86
Induction of a carcinogenic oncornavirus in C57BL/6 mouse embryo cells by 5-iododeoxyuridine. Nature (1975) 0.85
Endoscopic paravariceal injection sclerotherapy of the esophagus--indications, technique, complications: results of a period of 14 years. Gastrointest Endosc (1983) 0.85
[Diagnostic and therapeutic measures in acute catastrophic bleeding esophageal varices]. Fortschr Med (1976) 0.85
Prospective study comparing human albumin vs. reinfusion of ultrafiltrate-ascitic fluid after total paracentesis in cirrhotic patients with tense ascites. Z Gastroenterol (2001) 0.84
Is there an indication for prophylactic endoscopic paravariceal injection sclerotherapy in patients with liver cirrhosis and portal hypertension? Endoscopy (1986) 0.84
Comparative cellular and immunochemical studies of two cases of pyroglobulinemia. Am J Med (1968) 0.83
[Sclerosing the esophageal wall for acute, conservatively not curable and imminent varicose bleeding]. Dtsch Med Wochenschr (1977) 0.82
[Immediate sclerotherapy of acute hemorrhaging esophageal varices in emergency endoscopy. A prospective study]. Dtsch Med Wochenschr (1986) 0.82
Hollow fiber bioartificial liver utilizing collagen-entrapped porcine hepatocyte spheroids. Biotechnol Bioeng (1996) 0.82
[Sclerotherapy for the prevention of bleeding esophageal varices]. Internist (Berl) (1983) 0.82
Gynecologic moniliasis. Incidence with various contraceptive methods. J Med Soc N J (1971) 0.81
Mesocaval interposition shunt with small-diameter polytetrafluoroethylene grafts in sclerotherapy failure. Br J Surg (1995) 0.80
Development of a bioartificial liver employing xenogeneic hepatocytes. Cytotechnology (1997) 0.80
Current therapeutic strategy in bleeding esophageal varices in babies and children and long-term results of endoscopic paravariceal sclerotherapy over twenty years. Eur J Pediatr Surg (1994) 0.80
Multiscale morphology of organic semiconductor thin films controls the adhesion and viability of human neural cells. Biophys J (2010) 0.80
An IgM pyroglobulin associated with lymphosarcoma. Am J Med (1970) 0.79
Purification and properties of the alpha-interferon receptor of human lymphoblastoid (Namalva) cells. J Biol Chem (1984) 0.79
Interferon production by a human lymphoblastoid cell line (DG-75) free of the Epstein-Barr genome. Antimicrob Agents Chemother (1981) 0.79
Health and well-being among elderly persons in Israel: the role of social class and immigration status. Ethn Health (1998) 0.78
[Correlation between pulmonary hypertension and portal hypertension--2 case reports of different forms of pre-sinusoidal portal hypertension]. Leber Magen Darm (1994) 0.78
No role for the CYP3A5*3 polymorphism in intestinal and hepatic metabolism of midazolam. Eur J Clin Pharmacol (2008) 0.78
[Electronmicroscopic, morphometric and histologic studies on rat livers after ligature of a portal branch]. Beitr Pathol (1972) 0.78
How insurers, purchasers, and employers view their need for guidelines: report of Washington Business Group on Health--AHCPR focus groups. QRB Qual Rev Bull (1992) 0.78
The carbon-tetrachloride-hepatotoxicity as a model of liver damage. First report: Long-time biochemical changes. Acta Hepatogastroenterol (Stuttg) (1975) 0.78
[Sclerosing of the esophageal wall in the management of acute bleeding in esophageal varices and impending hemorrhage in decompensated liver function]. Z Gastroenterol (1974) 0.78
The presence of B7-H4+ macrophages and CD25+CD4+ and FOXP3+ regulatory T cells in the microenvironment of nasal polyps - a preliminary report. Folia Histochem Cytobiol (2010) 0.78
[Experimental studies on the function of an isolated kidney in pulsatory and continuous perfusion. 2]. Bruns Beitr Klin Chir (1965) 0.78
Hemodynamic studies on normothermic perfusion of the isolated pig kidney with pulsatile and non pulsatile flows. J Cardiovasc Surg (Torino) (1969) 0.78
Electron microscopic, microangiographic and cytophotometric studies on dog livers after various methods of preservation. Eur Surg Res (1972) 0.77
Media for cultivation of animal cells: an overview. Cytotechnology (1988) 0.77
Surgery for cirrhotic patients with hepatocellular carcinoma and hypersplenism. Surg Endosc (2001) 0.77
The absolute number of circulating CD34+ cells as the best predictor of peripheral hematopoietic stem cell yield. J Hematother (1999) 0.77
[Small unilocular hepatocellular carcinoma (0 < 5 cm) in patients with liver cirrhosis. Early diagnosis, surgical indications, resection and prognosis]. Zentralbl Chir (2000) 0.77
[A new therapeutic concept for the selection of liver cirrhotics with recurrent bleeding esophageal varices for selective shunt]. Chirurg (1979) 0.77
Equipment and procedures for production of monoclonal antibodies in culture. Adv Biotechnol Processes (1989) 0.77
[Focal nodular hyperplasia (author's transl)]. Rofo (1980) 0.77
Protein-calixarene interactions: complexation of Bovine Serum Albumin by sulfonatocalix[n]arenes. Chem Commun (Camb) (2001) 0.76
Long term variceal sclerotherapy: is endoscopic sclerosis a unique therapeutic approach and a true alternative to surgery? HPB Surg (1991) 0.76
[Telling the bad news: do the elderly want to know their diagnoses and participate in medical decision making?]. Harefuah (1997) 0.76
What is the aim of esophageal variceal sclerotherapy--prevention of rebleeding or complete obliteration of veins? J Clin Gastroenterol (1993) 0.75
[Guidelines of GASL and DGVS: transjugular intrahepatic portosystemic shunt (TIPS)--indications and results]. Z Gastroenterol (1997) 0.75
[Diagnosis of chronic hepatitis]. Dtsch Med Wochenschr (1998) 0.75
Analysis of the intensity of immune cell infiltration and immunoreactivity of RCAS1 in diffuse large B-cell lymphoma of the palatine tonsil and its microenvironment. Cell Tissue Res (2015) 0.75
[Acute intestinal hemorrhage in marked diverticulosis of the small intestine]. Dtsch Med Wochenschr (2002) 0.75
[Direct antegrade cholangiography and percutaneous transhepatic drainage of the biliary tract (author's transl)]. Rontgenblatter (1978) 0.75
[Emergency treatment of massive esophageal varices hemorrhage]. Dtsch Med Wochenschr (1977) 0.75
[Intrahepatic blockade in isolated heterologous liver perfusion]. Langenbecks Arch Chir (1968) 0.75
[A new simple table for the computation of blood volume and extracellular space]. Chirurg (1969) 0.75
[Results of transjugular antegrade cholangiography and retrograde portography (author's transl)]. Rontgenblatter (1977) 0.75
[New technic of the transjugular cava blocking in the removal of acute pelvic vein and inferior vena cava thrombosis]. Chirurg (1977) 0.75
[Vasographic diagnosis of liver echinococcosis]. Fortschr Geb Rontgenstr Nuklearmed (1971) 0.75
[Is the portocaval shunt in bleeding esophageal varices still defensible?]. Med Welt (1979) 0.75
[Indications for shunt operation]. Dtsch Med Wochenschr (1971) 0.75
[The value of sclerosing of the esophageal wall and of gastro-esophageal disconnection for the therapy of massive, intractable hemorrhage from esophageal varices in portal hypertension]. Verh Dtsch Ges Inn Med (1976) 0.75
[Liver transplantation in humans]. Dtsch Med J (1971) 0.75
[Fiber-endoscopic scarification of esophageal varices or esophageal wall sclerotization using the fiber endoscope?]. Dtsch Med Wochenschr (1979) 0.75
[Sclerosing therapy of esophageal varices]. Tijdschr Gastroenterol (1978) 0.75
The fibrinolytic therapy of thrombosed portal veins and shunts in liver cirrhosis with portal hypertension and in prehepatic block. J Cardiovasc Surg (Torino) (1971) 0.75
[Report of experience with homologous liver transplantation]. Dtsch Med Wochenschr (1969) 0.75
[Organ preservation, surgical technic and immunosuppression in kidney transplantations]. Dtsch Med Wochenschr (1968) 0.75
[Endoscopical findings and therapeutic decision in osteomyelosclerosis associated with portal hypertension and bleeding from esophageal varices (author's transl)]. Leber Magen Darm (1976) 0.75
[Therapy of acute and threatened hemorrhage from esophageal varices by sclerosing the esophagcal wall in childhood]. Monatsschr Kinderheilkd (1977) 0.75